Clinical Trial Update: Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

View source ↗

Summary

Clinical trial update describing investigation of predictive biomarkers in patients with advanced biliary tract cancer treated with lenvatinib plus pembrolizuma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• LENVIMA (lenvatinib)

Snippet

Sponsor: CHA University | Conditions: Biliary Tract Cancer, Cholangiocarcinoma | Status: RECRUITING